ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:06 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 1373
Drug details and screening numbers
Drug Name: Dabrafenib
Drug ID: 1373
Synonyms: GSK2118436
Brand name: Tafinlar
Target: BRAF
Number of cell lines screened: 873
Screening concentration range(s): 0.0390625 to 10 uM
Statistically significant associations identified = 2
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a2 |
BRAF_mut |
1373 |
1 |
1 |
Dabrafenib |
BRAF |
72 |
798 |
2.3 |
3.62 |
-0.659 |
-4.28 |
2.7 ** |
3.1 ** |
1.4 * |
8.8e-45 |
1.26e-81 |
8.3e-02 |
7.3e-38 |
a121 |
TP53_mut |
1373 |
1 |
1 |
Dabrafenib |
BRAF |
577 |
293 |
2.3 |
2.63 |
3.59 |
0.957 |
0.5 . |
0.4 |
0.6 . |
2.05e-05 |
6.24e-67 |
1.19e-01 |
2.8 |
All-tests volcano plot